Saturday, 21 September 2013

Improvement in ß-Cell Secretory Capacity After Human Islet Transplantation According to the CIT07 Protocol

These data indicate that engrafted islet ß-cell mass is markedly improved with the CIT07 protocol, especially given more frequent use of single islet donors. Although several peritransplant differences may have each contributed to this improvement, the lack of deterioration in ß-cell secretory capacity over time in the CIT07 protocol suggests that low-dose tacrolimus and sirolimus are not toxic to islets (Diabetes)

No comments:

Post a Comment